| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calmodulin binding | 2.60e-07 | 230 | 101 | 10 | GO:0005516 | |
| GeneOntologyMolecularFunction | nucleobase-containing compound transmembrane transporter activity | 5.23e-07 | 59 | 101 | 6 | GO:0015932 | |
| GeneOntologyMolecularFunction | nucleotide transmembrane transporter activity | 6.35e-07 | 33 | 101 | 5 | GO:0015215 | |
| GeneOntologyMolecularFunction | organophosphate ester transmembrane transporter activity | 1.50e-06 | 39 | 101 | 5 | GO:0015605 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | ABCC3 SLC25A42 PSG1 PSG4 PSG9 GRIK5 SLCO5A1 SLC22A2 SLC25A23 SLC38A3 | 2.35e-06 | 293 | 101 | 10 | GO:0008514 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | ABCC3 SLC25A42 PSG1 PSG4 PSG9 SLC25A33 ANO1 GRIK5 TMC3 BCS1L SLC25A51 KCNH4 SLCO5A1 KCNA1 KCNA6 SLC22A2 SLC25A52 SLC25A23 SLC38A3 | 6.27e-06 | 1180 | 101 | 19 | GO:0022857 |
| GeneOntologyMolecularFunction | phosphatase binding | 7.79e-06 | 264 | 101 | 9 | GO:0019902 | |
| GeneOntologyMolecularFunction | adenine nucleotide transmembrane transporter activity | 8.46e-06 | 26 | 101 | 4 | GO:0000295 | |
| GeneOntologyMolecularFunction | purine nucleotide transmembrane transporter activity | 1.33e-05 | 29 | 101 | 4 | GO:0015216 | |
| GeneOntologyMolecularFunction | Toll-like receptor binding | 1.33e-05 | 29 | 101 | 4 | GO:0035325 | |
| GeneOntologyMolecularFunction | transporter activity | ABCC3 SLC25A42 PSG1 PSG4 PSG9 SLC25A33 ANO1 GRIK5 TMC3 BCS1L SLC25A51 KCNH4 SLCO5A1 KCNA1 KCNA6 SLC22A2 SLC25A52 SLC25A23 SLC38A3 | 2.18e-05 | 1289 | 101 | 19 | GO:0005215 |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 2.54e-05 | 34 | 101 | 4 | GO:0015125 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 3.43e-05 | 73 | 101 | 5 | GO:0170055 | |
| GeneOntologyMolecularFunction | granulocyte colony-stimulating factor receptor binding | 4.39e-05 | 14 | 101 | 3 | GO:0005130 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 8.77e-05 | 207 | 101 | 7 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 9.04e-05 | 208 | 101 | 7 | GO:0005342 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase binding | 1.10e-04 | 149 | 101 | 6 | GO:1990782 | |
| GeneOntologyMolecularFunction | GPI anchor binding | 2.07e-04 | 23 | 101 | 3 | GO:0034235 | |
| GeneOntologyMolecularFunction | carbohydrate derivative transmembrane transporter activity | 2.27e-04 | 59 | 101 | 4 | GO:1901505 | |
| GeneOntologyMolecularFunction | exopeptidase activity | 2.41e-04 | 110 | 101 | 5 | GO:0008238 | |
| GeneOntologyMolecularFunction | NAD transmembrane transporter activity | 2.51e-04 | 5 | 101 | 2 | GO:0051724 | |
| GeneOntologyMolecularFunction | filamin binding | 4.17e-04 | 29 | 101 | 3 | GO:0031005 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 4.38e-04 | 70 | 101 | 4 | GO:1901618 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 4.85e-04 | 196 | 101 | 6 | GO:0005319 | |
| GeneOntologyMolecularFunction | steroid binding | 5.77e-04 | 133 | 101 | 5 | GO:0005496 | |
| GeneOntologyMolecularFunction | RS domain binding | 6.95e-04 | 8 | 101 | 2 | GO:0050733 | |
| GeneOntologyMolecularFunction | protein phosphatase binding | 6.96e-04 | 210 | 101 | 6 | GO:0019903 | |
| GeneOntologyMolecularFunction | dinucleotide phosphatase activity | 8.91e-04 | 9 | 101 | 2 | GO:0004551 | |
| GeneOntologyMolecularFunction | vitamin D binding | 8.91e-04 | 9 | 101 | 2 | GO:0005499 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 9.09e-04 | 599 | 101 | 10 | GO:0050839 | |
| GeneOntologyMolecularFunction | microfilament motor activity | 9.32e-04 | 38 | 101 | 3 | GO:0000146 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 1.13e-03 | 90 | 101 | 4 | GO:0008028 | |
| GeneOntologyMolecularFunction | ADP transmembrane transporter activity | 1.35e-03 | 11 | 101 | 2 | GO:0015217 | |
| GeneOntologyMolecularFunction | DNA endonuclease activity | 1.43e-03 | 44 | 101 | 3 | GO:0004520 | |
| GeneOntologyMolecularFunction | protein kinase binding | PSG1 PSG4 PSG7 PSG9 TNS2 CEP192 ADD3 PIK3R2 SYK SMO PAX6 HYAL2 | 1.51e-03 | 873 | 101 | 12 | GO:0019901 |
| GeneOntologyMolecularFunction | glycolipid binding | 1.95e-03 | 49 | 101 | 3 | GO:0051861 | |
| GeneOntologyMolecularFunction | carboxypeptidase activity | 1.95e-03 | 49 | 101 | 3 | GO:0004180 | |
| GeneOntologyMolecularFunction | integrin binding | 1.96e-03 | 175 | 101 | 5 | GO:0005178 | |
| GeneOntologyMolecularFunction | azole transmembrane transporter activity | 2.22e-03 | 14 | 101 | 2 | GO:1901474 | |
| GeneOntologyMolecularFunction | endodeoxyribonuclease activity, producing 5'-phosphomonoesters | 2.22e-03 | 14 | 101 | 2 | GO:0016888 | |
| GeneOntologyMolecularFunction | ATP transmembrane transporter activity | 2.22e-03 | 14 | 101 | 2 | GO:0005347 | |
| GeneOntologyMolecularFunction | icosanoid transmembrane transporter activity | 2.55e-03 | 15 | 101 | 2 | GO:0071714 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on ester bonds | ABHD15 CILP CAMK2G PPM1E APEX1 TNS2 XRCC1 FASN PTPRB NME7 SLX1A | 2.55e-03 | 807 | 101 | 11 | GO:0016788 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 2.68e-03 | 188 | 101 | 5 | GO:0005201 | |
| GeneOntologyMolecularFunction | kinase binding | PSG1 PSG4 PSG7 PSG9 TNS2 CEP192 ADD3 PIK3R2 SYK SMO PAX6 HYAL2 | 3.57e-03 | 969 | 101 | 12 | GO:0019900 |
| GeneOntologyMolecularFunction | potassium channel activity | 4.07e-03 | 128 | 101 | 4 | GO:0005267 | |
| GeneOntologyMolecularFunction | lipid binding | COMP PSG1 PSG4 PSG9 PSMA1 TNS2 MYO1B KL SCAP SPHK1 SLC22A2 SMO | 4.17e-03 | 988 | 101 | 12 | GO:0008289 |
| GeneOntologyMolecularFunction | basic amino acid transmembrane transporter activity | 4.54e-03 | 20 | 101 | 2 | GO:0015174 | |
| GeneOntologyMolecularFunction | DNA nuclease activity | 4.76e-03 | 67 | 101 | 3 | GO:0004536 | |
| GeneOntologyBiologicalProcess | nucleotide transmembrane transport | 4.11e-07 | 31 | 102 | 5 | GO:1901679 | |
| GeneOntologyBiologicalProcess | purine-containing compound transmembrane transport | 1.54e-06 | 40 | 102 | 5 | GO:0072530 | |
| GeneOntologyBiologicalProcess | negative regulation of hepatocyte proliferation | 2.57e-06 | 20 | 102 | 4 | GO:2000346 | |
| GeneOntologyBiologicalProcess | nucleotide transport | 4.76e-06 | 50 | 102 | 5 | GO:0006862 | |
| GeneOntologyBiologicalProcess | fatty acid biosynthetic process | 4.87e-06 | 191 | 102 | 8 | GO:0006633 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid biosynthetic process | 5.77e-06 | 260 | 102 | 9 | GO:0072330 | |
| GeneOntologyBiologicalProcess | carboxylic acid biosynthetic process | 1.65e-05 | 374 | 102 | 10 | GO:0046394 | |
| GeneOntologyBiologicalProcess | organic acid biosynthetic process | 1.77e-05 | 377 | 102 | 10 | GO:0016053 | |
| GeneOntologyBiologicalProcess | mitochondrial NAD transmembrane transport | 2.42e-05 | 2 | 102 | 2 | GO:1990549 | |
| GeneOntologyBiologicalProcess | negative regulation of hemostasis | 2.51e-05 | 70 | 102 | 5 | GO:1900047 | |
| GeneOntologyBiologicalProcess | insulin metabolic process | 2.62e-05 | 35 | 102 | 4 | GO:1901142 | |
| GeneOntologyBiologicalProcess | regulation of hepatocyte proliferation | 3.66e-05 | 38 | 102 | 4 | GO:2000345 | |
| GeneOntologyBiologicalProcess | negative regulation of brown fat cell proliferation | 4.11e-05 | 14 | 102 | 3 | GO:0070348 | |
| GeneOntologyBiologicalProcess | positive regulation of protein serine/threonine kinase activity | 4.91e-05 | 193 | 102 | 7 | GO:0071902 | |
| GeneOntologyBiologicalProcess | regulation of brown fat cell proliferation | 5.12e-05 | 15 | 102 | 3 | GO:0070347 | |
| GeneOntologyBiologicalProcess | positive regulation of homophilic cell adhesion | 5.12e-05 | 15 | 102 | 3 | GO:1903387 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immune response to tumor cell | 5.12e-05 | 15 | 102 | 3 | GO:0002856 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 5.12e-05 | 15 | 102 | 3 | GO:0002859 | |
| GeneOntologyBiologicalProcess | vascular process in circulatory system | 5.28e-05 | 344 | 102 | 9 | GO:0003018 | |
| GeneOntologyBiologicalProcess | regulation of platelet aggregation | 5.46e-05 | 42 | 102 | 4 | GO:0090330 | |
| GeneOntologyBiologicalProcess | adenine nucleotide transport | 5.46e-05 | 42 | 102 | 4 | GO:0051503 | |
| GeneOntologyBiologicalProcess | insulin receptor internalization | 6.27e-05 | 16 | 102 | 3 | GO:0038016 | |
| GeneOntologyBiologicalProcess | purine nucleotide transport | 6.57e-05 | 44 | 102 | 4 | GO:0015865 | |
| GeneOntologyBiologicalProcess | regulation of body fluid levels | 6.78e-05 | 442 | 102 | 10 | GO:0050878 | |
| GeneOntologyBiologicalProcess | negative regulation of behavior | 7.19e-05 | 45 | 102 | 4 | GO:0048521 | |
| GeneOntologyBiologicalProcess | brown fat cell proliferation | 7.59e-05 | 17 | 102 | 3 | GO:0070342 | |
| GeneOntologyBiologicalProcess | insulin catabolic process | 7.59e-05 | 17 | 102 | 3 | GO:1901143 | |
| GeneOntologyBiologicalProcess | granulocyte colony-stimulating factor signaling pathway | 7.59e-05 | 17 | 102 | 3 | GO:0038158 | |
| GeneOntologyBiologicalProcess | epithelial cell proliferation involved in liver morphogenesis | 7.84e-05 | 46 | 102 | 4 | GO:0072575 | |
| GeneOntologyBiologicalProcess | hepatocyte proliferation | 7.84e-05 | 46 | 102 | 4 | GO:0072574 | |
| GeneOntologyBiologicalProcess | bile acid and bile salt transport | 8.54e-05 | 47 | 102 | 4 | GO:0015721 | |
| GeneOntologyBiologicalProcess | negative regulation of lipid biosynthetic process | 8.90e-05 | 91 | 102 | 5 | GO:0051055 | |
| GeneOntologyBiologicalProcess | regulation of homophilic cell adhesion | 9.08e-05 | 18 | 102 | 3 | GO:1903385 | |
| GeneOntologyBiologicalProcess | regulation of hemostasis | 9.86e-05 | 93 | 102 | 5 | GO:1900046 | |
| GeneOntologyBiologicalProcess | liver morphogenesis | 1.01e-04 | 49 | 102 | 4 | GO:0072576 | |
| GeneOntologyBiologicalProcess | platelet aggregation | 1.09e-04 | 95 | 102 | 5 | GO:0070527 | |
| GeneOntologyBiologicalProcess | growth | SEMA6C COMP PSG1 PSG4 TNC PSG9 SLC25A33 PKDCC TNS2 DDX3X DIPK2A SPHK1 PCDH15 SMO CDK1 MMP14 HYAL2 | 1.11e-04 | 1235 | 102 | 17 | GO:0040007 |
| GeneOntologyBiologicalProcess | regulation of homotypic cell-cell adhesion | 1.37e-04 | 53 | 102 | 4 | GO:0034110 | |
| GeneOntologyBiologicalProcess | negative regulation of fat cell proliferation | 1.46e-04 | 21 | 102 | 3 | GO:0070345 | |
| GeneOntologyBiologicalProcess | negative regulation of response to tumor cell | 1.46e-04 | 21 | 102 | 3 | GO:0002835 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response to tumor cell | 1.46e-04 | 21 | 102 | 3 | GO:0002838 | |
| GeneOntologyBiologicalProcess | positive regulation of protein import into nucleus | 1.47e-04 | 54 | 102 | 4 | GO:0042307 | |
| GeneOntologyBiologicalProcess | negative regulation of granulocyte differentiation | 1.69e-04 | 22 | 102 | 3 | GO:0030853 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet aggregation | 1.94e-04 | 23 | 102 | 3 | GO:0090331 | |
| GeneOntologyBiologicalProcess | cellular response to prostaglandin stimulus | 1.94e-04 | 23 | 102 | 3 | GO:0071379 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 1.94e-04 | 23 | 102 | 3 | GO:0002858 | |
| GeneOntologyBiologicalProcess | positive regulation of vasculogenesis | 2.20e-04 | 24 | 102 | 3 | GO:2001214 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immune response to tumor cell | 2.20e-04 | 24 | 102 | 3 | GO:0002855 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity directed against tumor cell target | 2.20e-04 | 24 | 102 | 3 | GO:0002420 | |
| GeneOntologyBiologicalProcess | granulocyte differentiation | 2.22e-04 | 60 | 102 | 4 | GO:0030851 | |
| GeneOntologyBiologicalProcess | organic anion transport | ABCC3 SLC25A42 PSG1 PSG4 PSG9 SLCO5A1 SLC22A2 SYK SLC25A23 SLC38A3 | 2.36e-04 | 515 | 102 | 10 | GO:0015711 |
| GeneOntologyBiologicalProcess | NAD transmembrane transport | 2.40e-04 | 5 | 102 | 2 | GO:0035352 | |
| GeneOntologyBiologicalProcess | common myeloid progenitor cell proliferation | 2.50e-04 | 25 | 102 | 3 | GO:0035726 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immune response to tumor cell | 2.50e-04 | 25 | 102 | 3 | GO:0002423 | |
| GeneOntologyBiologicalProcess | regulation of cell growth | 2.51e-04 | 519 | 102 | 10 | GO:0001558 | |
| GeneOntologyBiologicalProcess | anatomical structure homeostasis | 2.55e-04 | 334 | 102 | 8 | GO:0060249 | |
| GeneOntologyBiologicalProcess | tissue homeostasis | 2.55e-04 | 334 | 102 | 8 | GO:0001894 | |
| GeneOntologyBiologicalProcess | gland morphogenesis | 2.58e-04 | 178 | 102 | 6 | GO:0022612 | |
| GeneOntologyBiologicalProcess | cell growth | SEMA6C PSG1 PSG4 TNC PSG9 SLC25A33 DDX3X SPHK1 SMO MMP14 HYAL2 | 2.66e-04 | 625 | 102 | 11 | GO:0016049 |
| GeneOntologyBiologicalProcess | circulatory system process | TBXAS1 ABCC3 COMP PSG1 PSG4 PSG9 ADA ADD3 KL SLC22A2 SLC38A3 CTSZ | 2.68e-04 | 733 | 102 | 12 | GO:0003013 |
| GeneOntologyBiologicalProcess | response to insulin | 2.98e-04 | 342 | 102 | 8 | GO:0032868 | |
| GeneOntologyBiologicalProcess | regulation of fat cell proliferation | 3.15e-04 | 27 | 102 | 3 | GO:0070344 | |
| GeneOntologyBiologicalProcess | spliceosomal tri-snRNP complex assembly | 3.15e-04 | 27 | 102 | 3 | GO:0000244 | |
| GeneOntologyBiologicalProcess | regulation of platelet activation | 3.21e-04 | 66 | 102 | 4 | GO:0010543 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA splicing, via spliceosome | 3.52e-04 | 28 | 102 | 3 | GO:0048025 | |
| GeneOntologyBiologicalProcess | negative regulation of homotypic cell-cell adhesion | 3.52e-04 | 28 | 102 | 3 | GO:0034111 | |
| GeneOntologyBiologicalProcess | NAD transport | 3.59e-04 | 6 | 102 | 2 | GO:0043132 | |
| GeneOntologyBiologicalProcess | protein acetylation | 3.60e-04 | 68 | 102 | 4 | GO:0006473 | |
| GeneOntologyBiologicalProcess | homotypic cell-cell adhesion | 3.79e-04 | 124 | 102 | 5 | GO:0034109 | |
| GeneOntologyBiologicalProcess | negative regulation of blood coagulation | 3.81e-04 | 69 | 102 | 4 | GO:0030195 | |
| GeneOntologyBiologicalProcess | regulation of vasculogenesis | 3.91e-04 | 29 | 102 | 3 | GO:2001212 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA processing | 3.91e-04 | 29 | 102 | 3 | GO:0050686 | |
| GeneOntologyBiologicalProcess | cellular response to insulin stimulus | 3.99e-04 | 271 | 102 | 7 | GO:0032869 | |
| GeneOntologyBiologicalProcess | regulation of bone resorption | 4.02e-04 | 70 | 102 | 4 | GO:0045124 | |
| GeneOntologyBiologicalProcess | regulation of protein serine/threonine kinase activity | 4.05e-04 | 358 | 102 | 8 | GO:0071900 | |
| GeneOntologyBiologicalProcess | negative regulation of transferase activity | 4.17e-04 | 273 | 102 | 7 | GO:0051348 | |
| GeneOntologyBiologicalProcess | negative regulation of coagulation | 4.48e-04 | 72 | 102 | 4 | GO:0050819 | |
| GeneOntologyBiologicalProcess | regulation of growth | SEMA6C PSG1 PSG4 TNC PSG9 SLC25A33 DDX3X SPHK1 SMO CDK1 MMP14 HYAL2 | 4.54e-04 | 777 | 102 | 12 | GO:0040008 |
| GeneOntologyBiologicalProcess | cellular response to alcohol | 4.70e-04 | 130 | 102 | 5 | GO:0097306 | |
| GeneOntologyBiologicalProcess | regulation of fatty acid biosynthetic process | 4.72e-04 | 73 | 102 | 4 | GO:0042304 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet activation | 4.77e-04 | 31 | 102 | 3 | GO:0010544 | |
| GeneOntologyBiologicalProcess | small molecule biosynthetic process | 5.15e-04 | 676 | 102 | 11 | GO:0044283 | |
| GeneOntologyBiologicalProcess | negative regulation of bone resorption | 5.25e-04 | 32 | 102 | 3 | GO:0045779 | |
| GeneOntologyBiologicalProcess | fat cell proliferation | 5.25e-04 | 32 | 102 | 3 | GO:0070341 | |
| GeneOntologyBiologicalProcess | regulation of blood vessel remodeling | 5.25e-04 | 32 | 102 | 3 | GO:0060312 | |
| GeneOntologyBiologicalProcess | negative regulation of protein phosphorylation | 5.50e-04 | 375 | 102 | 8 | GO:0001933 | |
| GeneOntologyBiologicalProcess | regulation of granulocyte differentiation | 5.75e-04 | 33 | 102 | 3 | GO:0030852 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA splicing | 5.75e-04 | 33 | 102 | 3 | GO:0033119 | |
| GeneOntologyBiologicalProcess | negative regulation of feeding behavior | 5.75e-04 | 33 | 102 | 3 | GO:2000252 | |
| GeneOntologyBiologicalProcess | negative regulation of phosphate metabolic process | 6.09e-04 | 478 | 102 | 9 | GO:0045936 | |
| GeneOntologyBiologicalProcess | negative regulation of phosphorus metabolic process | 6.28e-04 | 480 | 102 | 9 | GO:0010563 | |
| GeneOntologyBiologicalProcess | negative regulation of vascular permeability | 6.29e-04 | 34 | 102 | 3 | GO:0043116 | |
| GeneOntologyBiologicalProcess | negative regulation of bone remodeling | 6.29e-04 | 34 | 102 | 3 | GO:0046851 | |
| GeneOntologyBiologicalProcess | positive regulation of nucleocytoplasmic transport | 6.37e-04 | 79 | 102 | 4 | GO:0046824 | |
| GeneOntologyBiologicalProcess | regulation of transferase activity | PSG1 PSG4 PSG9 PPM1E XRCC1 DDX3X DIPK2A PTPRB PRIM2 SYK HYAL2 SPATC1L | 6.56e-04 | 810 | 102 | 12 | GO:0051338 |
| GeneOntologyBiologicalProcess | contact inhibition | 6.65e-04 | 8 | 102 | 2 | GO:0060242 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid transport | 6.68e-04 | 213 | 102 | 6 | GO:0015718 | |
| GeneOntologyBiologicalProcess | regulation of bone remodeling | 6.68e-04 | 80 | 102 | 4 | GO:0046850 | |
| GeneOntologyBiologicalProcess | regulation of protein import into nucleus | 7.00e-04 | 81 | 102 | 4 | GO:0042306 | |
| GeneOntologyBiologicalProcess | cellular response to oxygen-containing compound | PSG1 PSG4 TNC PSG9 SLC25A33 TRIM41 PPM1E ANO1 APEX1 TNS2 ADCY3 SPHK1 PIK3R2 PRKAA2 SMO CDK1 PAX6 | 7.23e-04 | 1450 | 102 | 17 | GO:1901701 |
| GeneOntologyCellularComponent | apical part of cell | NAALADL1 MYO1A PSG1 MYO7A PSG4 PSG9 ANO1 MYO1B FAP KL KCNA1 SLC22A2 PRKAA2 OSMR SLC38A3 HYAL2 | 2.79e-08 | 592 | 102 | 16 | GO:0045177 |
| GeneOntologyCellularComponent | apical plasma membrane | NAALADL1 MYO1A PSG1 MYO7A PSG4 PSG9 ANO1 KL KCNA1 SLC22A2 PRKAA2 OSMR SLC38A3 HYAL2 | 1.05e-07 | 487 | 102 | 14 | GO:0016324 |
| GeneOntologyCellularComponent | ciliary membrane | 8.52e-06 | 98 | 102 | 6 | GO:0060170 | |
| GeneOntologyCellularComponent | transforming growth factor beta ligand-receptor complex | 6.03e-05 | 16 | 102 | 3 | GO:0070021 | |
| GeneOntologyCellularComponent | basal part of cell | 9.80e-05 | 378 | 102 | 9 | GO:0045178 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | 1.74e-04 | 320 | 102 | 8 | GO:0016323 | |
| GeneOntologyCellularComponent | basal plasma membrane | 3.44e-04 | 354 | 102 | 8 | GO:0009925 | |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | 7.92e-04 | 223 | 102 | 6 | GO:0098862 | |
| GeneOntologyCellularComponent | lateral plasma membrane | 9.90e-04 | 90 | 102 | 4 | GO:0016328 | |
| GeneOntologyCellularComponent | perisynaptic extracellular matrix | 1.26e-03 | 11 | 102 | 2 | GO:0098966 | |
| GeneOntologyCellularComponent | transferase complex, transferring phosphorus-containing groups | 1.28e-03 | 335 | 102 | 7 | GO:0061695 | |
| GeneOntologyCellularComponent | cilium | CEP104 DCDC2 PSG1 MYO7A PSG4 PSG9 MXRA8 KLC2 ADCY3 PCDH15 SMO NME7 | 1.42e-03 | 898 | 102 | 12 | GO:0005929 |
| GeneOntologyCellularComponent | protein kinase complex | 1.48e-03 | 170 | 102 | 5 | GO:1902911 | |
| GeneOntologyCellularComponent | potassium channel complex | 1.69e-03 | 104 | 102 | 4 | GO:0034705 | |
| GeneOntologyCellularComponent | synapse-associated extracellular matrix | 1.78e-03 | 13 | 102 | 2 | GO:0099535 | |
| Domain | - | 1.03e-05 | 53 | 102 | 5 | 1.50.40.10 | |
| Domain | Mito_carr | 1.03e-05 | 53 | 102 | 5 | PF00153 | |
| Domain | SOLCAR | 1.03e-05 | 53 | 102 | 5 | PS50920 | |
| Domain | Mitochondrial_sb/sol_carrier | 1.03e-05 | 53 | 102 | 5 | IPR018108 | |
| Domain | Mt_carrier_dom | 1.03e-05 | 53 | 102 | 5 | IPR023395 | |
| Domain | - | COL12A1 CILP PSG1 PSG4 TNC PSG7 PSG9 MXRA8 HAPLN4 PTPRB PLXNC1 OSMR | 2.64e-04 | 663 | 102 | 12 | 2.60.40.10 |
| Domain | PIP49_C | 4.37e-04 | 6 | 102 | 2 | PF12260 | |
| Domain | FAM69_kinase_dom | 4.37e-04 | 6 | 102 | 2 | IPR022049 | |
| Domain | Ig-like_fold | COL12A1 CILP PSG1 PSG4 TNC PSG7 PSG9 MXRA8 HAPLN4 PTPRB PLXNC1 OSMR | 4.66e-04 | 706 | 102 | 12 | IPR013783 |
| Domain | V-set | 5.19e-04 | 184 | 102 | 6 | PF07686 | |
| Domain | Myosin_TH1 | 6.09e-04 | 7 | 102 | 2 | PF06017 | |
| Domain | Myosin_TH1 | 6.09e-04 | 7 | 102 | 2 | IPR010926 | |
| Domain | TH1 | 6.09e-04 | 7 | 102 | 2 | PS51757 | |
| Domain | Ig_2 | 6.84e-04 | 73 | 102 | 4 | PF13895 | |
| Domain | Ig_V-set | 7.82e-04 | 199 | 102 | 6 | IPR013106 | |
| Domain | K_chnl_volt-dep_Kv1 | 8.09e-04 | 8 | 102 | 2 | IPR003972 | |
| Domain | Myosin_head_motor_dom | 1.16e-03 | 38 | 102 | 3 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 1.16e-03 | 38 | 102 | 3 | PS51456 | |
| Domain | Myosin_head | 1.16e-03 | 38 | 102 | 3 | PF00063 | |
| Domain | MYSc | 1.16e-03 | 38 | 102 | 3 | SM00242 | |
| Pubmed | A ciliopathy complex at the transition zone protects the cilia as a privileged membrane domain. | 1.40e-09 | 38 | 102 | 6 | 22179047 | |
| Pubmed | Characterization of cDNA encoding novel pregnancy-specific glycoprotein variants. | 2.42e-09 | 7 | 102 | 4 | 7794280 | |
| Pubmed | Insulin acutely decreases hepatic fatty acid synthase activity. | 9.28e-08 | 15 | 102 | 4 | 16054098 | |
| Pubmed | Mutations of the protocadherin gene PCDH15 cause Usher syndrome type 1F. | 2.44e-07 | 5 | 102 | 3 | 11398101 | |
| Pubmed | 2.61e-07 | 19 | 102 | 4 | 22496641 | ||
| Pubmed | The mitochondrial transporter family SLC25: identification, properties and physiopathology. | 5.04e-07 | 53 | 102 | 5 | 23266187 | |
| Pubmed | 1.36e-06 | 8 | 102 | 3 | 1690992 | ||
| Pubmed | 4.77e-06 | 38 | 102 | 4 | 32541003 | ||
| Pubmed | A mouse carcinoembryonic antigen gene family member is a calcium-dependent cell adhesion molecule. | 6.86e-06 | 13 | 102 | 3 | 1985902 | |
| Pubmed | CEACAM1+ myeloid cells control angiogenesis in inflammation. | 6.86e-06 | 13 | 102 | 3 | 19273835 | |
| Pubmed | Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1. | 6.86e-06 | 13 | 102 | 3 | 16638824 | |
| Pubmed | 6.86e-06 | 13 | 102 | 3 | 20044046 | ||
| Pubmed | 6.86e-06 | 13 | 102 | 3 | 32150576 | ||
| Pubmed | 6.86e-06 | 13 | 102 | 3 | 6265583 | ||
| Pubmed | 6.86e-06 | 13 | 102 | 3 | 34440862 | ||
| Pubmed | CEACAM1 is a potent regulator of B cell receptor complex-induced activation. | 6.86e-06 | 13 | 102 | 3 | 12832451 | |
| Pubmed | 6.86e-06 | 13 | 102 | 3 | 25406283 | ||
| Pubmed | Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor. | 6.86e-06 | 13 | 102 | 3 | 21670291 | |
| Pubmed | 6.86e-06 | 13 | 102 | 3 | 22162753 | ||
| Pubmed | 6.86e-06 | 13 | 102 | 3 | 2702644 | ||
| Pubmed | 6.86e-06 | 13 | 102 | 3 | 8380065 | ||
| Pubmed | 6.86e-06 | 13 | 102 | 3 | 1279194 | ||
| Pubmed | 6.86e-06 | 13 | 102 | 3 | 25724769 | ||
| Pubmed | 6.86e-06 | 13 | 102 | 3 | 26374765 | ||
| Pubmed | CEACAM1 deficiency delays important wound healing processes. | 6.86e-06 | 13 | 102 | 3 | 22092845 | |
| Pubmed | 6.86e-06 | 13 | 102 | 3 | 11801635 | ||
| Pubmed | 6.86e-06 | 13 | 102 | 3 | 28913658 | ||
| Pubmed | Expression of the Bgp gene and characterization of mouse colon biliary glycoprotein isoforms. | 6.86e-06 | 13 | 102 | 3 | 8500759 | |
| Pubmed | Mouse susceptibility to mouse hepatitis virus infection is linked to viral receptor genotype. | 6.86e-06 | 13 | 102 | 3 | 9343248 | |
| Pubmed | Ceacam1 deletion causes vascular alterations in large vessels. | 6.86e-06 | 13 | 102 | 3 | 23800882 | |
| Pubmed | 6.86e-06 | 13 | 102 | 3 | 19285068 | ||
| Pubmed | 6.86e-06 | 13 | 102 | 3 | 21760897 | ||
| Pubmed | 6.86e-06 | 13 | 102 | 3 | 1719235 | ||
| Pubmed | Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. | 6.86e-06 | 13 | 102 | 3 | 1326665 | |
| Pubmed | Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation. | 6.86e-06 | 13 | 102 | 3 | 39168268 | |
| Pubmed | 6.86e-06 | 13 | 102 | 3 | 8402684 | ||
| Pubmed | 6.86e-06 | 13 | 102 | 3 | 16619040 | ||
| Pubmed | 6.86e-06 | 13 | 102 | 3 | 29377208 | ||
| Pubmed | Expression of MHV-A59 receptor glycoproteins in susceptible and resistant strains of mice. | 6.86e-06 | 13 | 102 | 3 | 8209741 | |
| Pubmed | 6.86e-06 | 13 | 102 | 3 | 27002145 | ||
| Pubmed | Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis. | 6.86e-06 | 13 | 102 | 3 | 21949477 | |
| Pubmed | 6.86e-06 | 13 | 102 | 3 | 26219866 | ||
| Pubmed | 6.86e-06 | 13 | 102 | 3 | 2133556 | ||
| Pubmed | 6.86e-06 | 13 | 102 | 3 | 32521208 | ||
| Pubmed | 6.86e-06 | 13 | 102 | 3 | 19406938 | ||
| Pubmed | 6.86e-06 | 13 | 102 | 3 | 19621080 | ||
| Pubmed | CEACAM1 promotes CD8+ T cell responses and improves control of a chronic viral infection. | 6.86e-06 | 13 | 102 | 3 | 29967450 | |
| Pubmed | Expression of newly identified secretory CEACAM1(a) isoforms in the intestinal epithelium. | 6.86e-06 | 13 | 102 | 3 | 19358828 | |
| Pubmed | 6.86e-06 | 13 | 102 | 3 | 16680193 | ||
| Pubmed | 6.86e-06 | 13 | 102 | 3 | 1653760 | ||
| Pubmed | A rational nomenclature for serine/arginine-rich protein splicing factors (SR proteins). | 6.86e-06 | 13 | 102 | 3 | 20516191 | |
| Pubmed | Regulation of hepatic fibrosis by carcinoembryonic antigen-related cell adhesion molecule 1. | 6.86e-06 | 13 | 102 | 3 | 34058224 | |
| Pubmed | 6.86e-06 | 13 | 102 | 3 | 10964771 | ||
| Pubmed | 6.86e-06 | 13 | 102 | 3 | 32169849 | ||
| Pubmed | 6.86e-06 | 13 | 102 | 3 | 22469976 | ||
| Pubmed | CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation. | 6.86e-06 | 13 | 102 | 3 | 21532628 | |
| Pubmed | Structural and Molecular Evidence Suggesting Coronavirus-driven Evolution of Mouse Receptor. | 6.86e-06 | 13 | 102 | 3 | 28035001 | |
| Pubmed | Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice. | 6.86e-06 | 13 | 102 | 3 | 15316023 | |
| Pubmed | In vivo adaptation and persistence of Neisseria meningitidis within the nasopharyngeal mucosa. | 6.86e-06 | 13 | 102 | 3 | 23935487 | |
| Pubmed | 6.86e-06 | 13 | 102 | 3 | 15331748 | ||
| Pubmed | 6.86e-06 | 13 | 102 | 3 | 22673933 | ||
| Pubmed | Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1. | 6.86e-06 | 13 | 102 | 3 | 22406619 | |
| Pubmed | 6.86e-06 | 13 | 102 | 3 | 7628460 | ||
| Pubmed | Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance. | 6.86e-06 | 13 | 102 | 3 | 25972571 | |
| Pubmed | 6.86e-06 | 13 | 102 | 3 | 19008452 | ||
| Pubmed | 6.86e-06 | 13 | 102 | 3 | 18544705 | ||
| Pubmed | Expression of the mouse hepatitis virus receptor by central nervous system microglia. | 6.86e-06 | 13 | 102 | 3 | 15220458 | |
| Pubmed | 6.86e-06 | 13 | 102 | 3 | 18843289 | ||
| Pubmed | 6.86e-06 | 13 | 102 | 3 | 15207636 | ||
| Pubmed | 6.86e-06 | 13 | 102 | 3 | 21081647 | ||
| Pubmed | 6.86e-06 | 13 | 102 | 3 | 11133662 | ||
| Pubmed | 6.86e-06 | 13 | 102 | 3 | 11483763 | ||
| Pubmed | 6.86e-06 | 13 | 102 | 3 | 2164599 | ||
| Pubmed | 6.86e-06 | 13 | 102 | 3 | 29396368 | ||
| Pubmed | 6.86e-06 | 13 | 102 | 3 | 18003729 | ||
| Pubmed | 6.86e-06 | 13 | 102 | 3 | 26284027 | ||
| Pubmed | CEACAM1 specifically suppresses B cell receptor signaling-mediated activation. | 6.86e-06 | 13 | 102 | 3 | 33352461 | |
| Pubmed | 6.86e-06 | 13 | 102 | 3 | 38381498 | ||
| Pubmed | 6.86e-06 | 13 | 102 | 3 | 20739537 | ||
| Pubmed | 6.86e-06 | 13 | 102 | 3 | 1633107 | ||
| Pubmed | The role of CEA-related cell adhesion molecule-1 (CEACAM1) in vascular homeostasis. | 6.86e-06 | 13 | 102 | 3 | 27695943 | |
| Pubmed | 6.86e-06 | 13 | 102 | 3 | 20404914 | ||
| Pubmed | 6.86e-06 | 13 | 102 | 3 | 26911181 | ||
| Pubmed | Hepatic CEACAM1 expression indicates donor liver quality and prevents early transplantation injury. | 6.86e-06 | 13 | 102 | 3 | 32027621 | |
| Pubmed | 6.86e-06 | 13 | 102 | 3 | 30664851 | ||
| Pubmed | Role for hepatic CEACAM1 in regulating fatty acid metabolism along the adipocyte-hepatocyte axis. | 6.86e-06 | 13 | 102 | 3 | 27777319 | |
| Pubmed | 6.86e-06 | 13 | 102 | 3 | 18848945 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 2328001 | ||
| Pubmed | Evidence of genetic heterogeneity in Alberta Hutterites with Usher syndrome type I. | 8.52e-06 | 2 | 102 | 2 | 22690115 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 31827649 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 15816625 | ||
| Pubmed | Base excision repair genes XRCC1 and APEX1 and the risk for prostate cancer. | 8.52e-06 | 2 | 102 | 2 | 20852942 | |
| Pubmed | SRSF9 promotes cell proliferation and migration of glioblastoma through enhancing CDK1 expression. | 8.52e-06 | 2 | 102 | 2 | 38842611 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 27925687 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 15044328 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 16406883 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 21420246 | ||
| Pubmed | PSG7 and 9 (Pregnancy-Specific β-1 Glycoproteins 7 and 9): Novel Biomarkers for Preeclampsia. | 8.52e-06 | 2 | 102 | 2 | 35322669 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 19073198 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 32906142 | ||
| Cytoband | 19q13.2 | 3.68e-09 | 164 | 102 | 8 | 19q13.2 | |
| GeneFamily | CD molecules|V-set domain containing|Pregnancy specific glycoproteins | 9.81e-08 | 11 | 77 | 4 | 1315 | |
| GeneFamily | RNA binding motif containing|Serine and arginine rich splicing factors | 1.59e-05 | 12 | 77 | 3 | 737 | |
| GeneFamily | Solute carriers | SLC25A42 SLC25A33 SLC25A51 SLCO5A1 SLC22A2 SLC25A52 SLC25A23 SLC38A3 | 2.73e-04 | 395 | 77 | 8 | 752 |
| GeneFamily | Myosins, class I | 4.93e-04 | 8 | 77 | 2 | 1097 | |
| GeneFamily | Potassium voltage-gated channels | 6.55e-04 | 40 | 77 | 3 | 274 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 6.56e-04 | 163 | 77 | 5 | 590 | |
| GeneFamily | Endogenous ligands|Matrix metallopeptidases | 4.65e-03 | 24 | 77 | 2 | 891 | |
| GeneFamily | Fibronectin type III domain containing | 4.84e-03 | 160 | 77 | 4 | 555 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 7.45e-03 | 181 | 77 | 4 | 694 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_3_4WK_UP | 3.36e-06 | 230 | 102 | 8 | MM986 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.30e-10 | 198 | 102 | 9 | 8b9e8eaeffda40912a0163fdf39b93bc5e64751c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.30e-10 | 198 | 102 | 9 | eb78b2ae6a787dbc75947e8dd5a03693285bc8be | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-Myofibroblasts|Fibroblasts / Location, Cell class and cell subclass | 1.76e-08 | 73 | 102 | 6 | 116259a036373bccaeb77fe3c675741a5ca81c52 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-08 | 197 | 102 | 8 | cfd4cc5fb8d7a60dd5c0d2a1a7bad7ba38c19d40 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.88e-08 | 198 | 102 | 8 | c55608633f66e3d434c5d81324efb07c5120d2c2 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.88e-08 | 198 | 102 | 8 | 3e5459038fc6ed95f529eb4d1dc5113e16c19012 | |
| ToppCell | facs-Lung-Endomucin-24m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.55e-08 | 162 | 102 | 7 | 497ae9f86a5e7946d0fde932b35719a382a6b691 | |
| ToppCell | facs-Lung-Endomucin-24m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.55e-08 | 162 | 102 | 7 | 7b2949eba2b4aea239d96ed82aafab13b07624eb | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.44e-07 | 172 | 102 | 7 | e37c0b5b547a7345179ab258dd2141fec7064c17 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Adenocarcinoma_Mixed_Subtype-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.68e-07 | 176 | 102 | 7 | 0923b01137d6f9956ca815b41102c81e82624065 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.96e-07 | 180 | 102 | 7 | 935c091bbcd6d10b81dc4731779e5bd98205c99f | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.96e-07 | 180 | 102 | 7 | 3dd384b7f3d9582b8fec9fe05100e466e6218b76 | |
| ToppCell | metastatic_Brain-Fibroblasts-Myofibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 2.03e-07 | 181 | 102 | 7 | bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.19e-07 | 183 | 102 | 7 | 803376f5260de83c48d4f7301278d078a32b3e6e | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.19e-07 | 183 | 102 | 7 | 6d98973098c6d20c5305bce6a83a549a7d8dbfba | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.19e-07 | 183 | 102 | 7 | cc7f5a17b40e8d901885174922e5fa8877643071 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass | 2.27e-07 | 184 | 102 | 7 | 0b336489c10e8c3c957795dd845454f03404382b | |
| ToppCell | Mesenchymal_cells-Osteo-CAR|World / Lineage and Cell class | 2.36e-07 | 185 | 102 | 7 | 16f1588893d09c864e0cb4f837a1b972a1a57baa | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-07 | 192 | 102 | 7 | b35f0e422070ba9c7c1d9ff3eace4edc10286cde | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.14e-07 | 193 | 102 | 7 | dc8e62df6121ee99b156aca6b1b3ae555739b6f2 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.14e-07 | 193 | 102 | 7 | e2ee077fd381bd906e6b4329f22e7d106e422a7f | |
| ToppCell | facs-Bladder-nan-18m-Epithelial-bladder_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-07 | 195 | 102 | 7 | 3e4f9ecfaa756386d816a26313b7229ec092d4e6 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.60e-07 | 197 | 102 | 7 | c165c6fd12dc649b39e920d8528e2eb65c61956b | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 3.73e-07 | 198 | 102 | 7 | 4f4632f26a2043c5e4ab89031b4229b5dca1bd48 | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-B_(Myofibroblast)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.73e-07 | 198 | 102 | 7 | 196257c4420ac801ed9fbb444f11718adb7560ae | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.86e-07 | 199 | 102 | 7 | edd5300da1a3b758210ff8f949e9d1988b8bc7e2 | |
| ToppCell | tumor_Lung-Fibroblasts-Myofibroblasts|Fibroblasts / Location, Cell class and cell subclass | 3.86e-07 | 199 | 102 | 7 | f89d67e3d8cd48ef5c30a5ad71764f4ebbc8bcb3 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.86e-07 | 199 | 102 | 7 | 63c01e8961f48ed1bed4ab619cacf318cd6de7b9 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-Macroglial-Astrocyte|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 3.99e-07 | 200 | 102 | 7 | 29f82e2ad2f1888b6b236a4392b88a84351b8ddc | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-4-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.99e-07 | 200 | 102 | 7 | 4dbe21cb63569f28c7017cda065ea5ee00d7254e | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.99e-07 | 200 | 102 | 7 | 082e718c1da3f4fdd33a001d15ad3ddb2be985c7 | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Fibroblasts-4|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 3.99e-07 | 200 | 102 | 7 | bde938e5a18844fb8cc1d1be5a086809f7e2b97d | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-4|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 3.99e-07 | 200 | 102 | 7 | 54b18c92daaa3b3368c0c46134b0c27e10c8dbb0 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-4|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.99e-07 | 200 | 102 | 7 | 8256511b099c3eab8e33194f90c9ff354e7cfe8e | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.99e-07 | 200 | 102 | 7 | 731e55070a7ff315091855bd88cda30e5a7e1a98 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-Macroglial|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 3.99e-07 | 200 | 102 | 7 | 1598a9e8efa72fda7d12df07e7716b326cdf1d5e | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|Fibroblasts / Location, Cell class and cell subclass | 2.16e-06 | 164 | 102 | 6 | 9b4a6007abae992db871d9f6f731d5af724de30d | |
| ToppCell | Mesenchymal_cells-Osteo-CAR|Mesenchymal_cells / Lineage and Cell class | 3.04e-06 | 174 | 102 | 6 | 430e3cd61bc2a471959faa40e817aa4dd7d82d28 | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25-31|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.35e-06 | 177 | 102 | 6 | 6b4fe717928814dafcd13090b1c90ea973938c6d | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.60e-06 | 187 | 102 | 6 | 9aa411ae9b5a923378a5daebb8bb2fc2613f2510 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.60e-06 | 187 | 102 | 6 | 15d6e158562d7d85af3ceaf955439b379c8fce81 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.60e-06 | 187 | 102 | 6 | f62074b631fd45ad299c69d71b09267b04d656ee | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.74e-06 | 188 | 102 | 6 | 0aa8747c2931b0c91f6d78bb2db8fd8ede6dd559 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.74e-06 | 188 | 102 | 6 | 32f22a4d8cb98fd8b8fa0fbf28ef9266d711d081 | |
| ToppCell | (3)_Chondrocytes-(31)_Chondro-hyper|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 4.89e-06 | 189 | 102 | 6 | 394b153393904c3dba51a6bfe338afd554e66649 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.04e-06 | 190 | 102 | 6 | a08c5929b05a4969852e351a93c4e4deb4c8d5b6 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.04e-06 | 190 | 102 | 6 | 25525fee1da8a808034d9c916159fd0b6b26bce8 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.04e-06 | 190 | 102 | 6 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-Myofibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 5.19e-06 | 191 | 102 | 6 | aa43b472bc8362f79ae63f09f1ca764718bbf22c | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.35e-06 | 192 | 102 | 6 | 11088878043a6ff95ba1970361256a82e434b80a | |
| ToppCell | (3)_Chondrocytes|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 5.35e-06 | 192 | 102 | 6 | 5d2b4830d025d3dbdf5623ce1c28d1036e1984a8 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma-early_osteoblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.51e-06 | 193 | 102 | 6 | 5e46a9f65e85aca78f825fdef88a95b97eec8743 | |
| ToppCell | Mesenchymal_cells-Arteriolar_fibro.|World / Lineage and Cell class | 5.68e-06 | 194 | 102 | 6 | c1e8923a50b4138a1e4c054c0c17b7f7122aa8a9 | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.68e-06 | 194 | 102 | 6 | b294056f9bdc243263cf36dce7b62564144b9de1 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.85e-06 | 195 | 102 | 6 | d2c9c58b46bf96f9a536e177b995e340b55c6750 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.85e-06 | 195 | 102 | 6 | fc43cd295f2cc3f6e9442232e028944f011c82cc | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.85e-06 | 195 | 102 | 6 | 47762d9e442fb1f6f0033e3e10f4c6e498d2c081 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.02e-06 | 196 | 102 | 6 | 61bee32ca299219f31a30b57124e44e85b798e9f | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.02e-06 | 196 | 102 | 6 | fcb275746bf51269ed8ba4cf93edb054a45f1ccd | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 6.02e-06 | 196 | 102 | 6 | 275e153347caf94edc0c50021bbab49c8696fecb | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.20e-06 | 197 | 102 | 6 | ab5d3ebc73bd7cfc64381d14b92878b370205186 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal-mesenchymal_stem_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.20e-06 | 197 | 102 | 6 | 3bb92dd8a94e2be3b7fe51c9a21b241215477ac7 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.20e-06 | 197 | 102 | 6 | 71786e9432e2d649f5d86f639abb25e7102deb67 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.20e-06 | 197 | 102 | 6 | 17344464fdcc5ba0c03959696b97c195f11e644c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.20e-06 | 197 | 102 | 6 | 4cf4e9553397cd8dee883dbec24f41bec41aff99 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.20e-06 | 197 | 102 | 6 | 5b8d0d7116b20d8e27541e88ec80c9f1f477e384 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW19-Macroglial-Astrocyte|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 6.38e-06 | 198 | 102 | 6 | bfad1c51cf884ff7ce89f8278820800582541dc7 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW19-Macroglial|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 6.38e-06 | 198 | 102 | 6 | 6372e65242236c497d9b3be147092897c1609d22 | |
| ToppCell | tumor_Lung-Fibroblasts-Myofibroblasts|tumor_Lung / Location, Cell class and cell subclass | 6.38e-06 | 198 | 102 | 6 | 31f9181dab689aabe9c6182c2ef7de65ba3f0ff6 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD16|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.38e-06 | 198 | 102 | 6 | 0b928a829844f49f4d47e88908af192cb919011f | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macro_CHIT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.38e-06 | 198 | 102 | 6 | 0b41b3d6c2db795320e8b65d40d85fb8b618cc34 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.38e-06 | 198 | 102 | 6 | 524305c5d7b1d53e86ec0af775efefa3e0955e47 | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma|TCGA-Bladder / Sample_Type by Project: Shred V9 | 6.38e-06 | 198 | 102 | 6 | 65875fbd99393cdd62595c713ab90db06d28081f | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.57e-06 | 199 | 102 | 6 | 9672230aa0bc6a7289050c955f5154ca183a5159 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.57e-06 | 199 | 102 | 6 | e18abe678da293bd01fae55e2f9ab6fdd643d02d | |
| ToppCell | ILEUM-inflamed-(8)_Activated_fibroblasts|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.57e-06 | 199 | 102 | 6 | 317f412996d463ddf2e6a52ff41d5d676c77f43f | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.57e-06 | 199 | 102 | 6 | 1fd7bbb8727607e6507848602a19bc86882ef2d5 | |
| ToppCell | metastatic_Lymph_Node-Epithelial_cells-Malignant_cells|metastatic_Lymph_Node / Location, Cell class and cell subclass | 6.76e-06 | 200 | 102 | 6 | 5e2def2e56f21bc7295cdcf3580f5c0d16a6a494 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-2,_SCARA5|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 6.76e-06 | 200 | 102 | 6 | 2022df85df94ab8cbb4e80e3fe9894c01051c5e0 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.76e-06 | 200 | 102 | 6 | ad3fb8ef0be45032369d1325024787fbe1dfb8d6 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 6.76e-06 | 200 | 102 | 6 | 69b41f5fb370aa8840a9ad7919d03ef1e57d1b5b | |
| ToppCell | metastatic_Lymph_Node-Epithelial_cells|metastatic_Lymph_Node / Location, Cell class and cell subclass | 6.76e-06 | 200 | 102 | 6 | 07408011b37d32a20164866cf5da9dd120985357 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.76e-06 | 200 | 102 | 6 | b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.76e-06 | 200 | 102 | 6 | c239e6f5d23caa9a59b83e9b352b2d6a691dcb28 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.76e-06 | 200 | 102 | 6 | 54806080b5e97859ee6a4a9b4f19e22021c218f5 | |
| ToppCell | AT1-AT2_cells-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 2.10e-05 | 145 | 102 | 5 | cd5de30fd948024e3ad043c9411ce9f2722178b2 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.89e-05 | 155 | 102 | 5 | 8fdda4e3657ac56188ae88ed3caf145f4d9d1567 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-T_cells-ILC3|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.79e-05 | 164 | 102 | 5 | 631ec9f54475dcc9d6b1c5bf6917e7fda4671034 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibrocyte|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.90e-05 | 165 | 102 | 5 | 8a52f2dbcbd2bc1662b5e3fac381463fdcc3bf14 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Degenerative_Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.02e-05 | 166 | 102 | 5 | dc443a3327dc8f9a0d808c3c6e06b0834d45f5c2 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-mesothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.13e-05 | 167 | 102 | 5 | 743df5908c1ceb43b34b240d9f9649f30f4142fa | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.13e-05 | 167 | 102 | 5 | 805129f887078340b260aa136b0ba19f2bd6ea03 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-mesothelial_cell-mesothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.13e-05 | 167 | 102 | 5 | 1adb566f98af0109c8cc6e36033b89651e2c75e7 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.13e-05 | 167 | 102 | 5 | 31cf8bf2eb523f6e7e319620648ff37fc09e2601 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.13e-05 | 167 | 102 | 5 | 3acb18428d1d33ad430c2fd031b1a91baee3c01d | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 4.50e-05 | 170 | 102 | 5 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.63e-05 | 171 | 102 | 5 | b0373ed8283ee1792b6a490bff93906546978593 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.63e-05 | 171 | 102 | 5 | b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuronal-Neuron|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 5.16e-05 | 175 | 102 | 5 | 2812ac2ef41d245db544697fb6da1883361c96e8 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.30e-05 | 176 | 102 | 5 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| Computational | Neighborhood of CDKN1C | 2.44e-05 | 27 | 69 | 4 | GNF2_CDKN1C | |
| Computational | Neighborhood of EGFR | 4.88e-05 | 32 | 69 | 4 | GNF2_EGFR | |
| Computational | Neighborhood of IGFBP1 | 7.01e-05 | 35 | 69 | 4 | GNF2_IGFBP1 | |
| Computational | Neighborhood of MMP11 | 1.45e-04 | 42 | 69 | 4 | GNF2_MMP11 | |
| Computational | Neighborhood of TIMP2 | 2.07e-04 | 46 | 69 | 4 | GNF2_TIMP2 | |
| Computational | Neighborhood of KISS1 | 2.65e-04 | 49 | 69 | 4 | GNF2_KISS1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.87e-04 | 50 | 69 | 4 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_8 | |
| Computational | Neighborhood of ARL3 | 6.97e-04 | 304 | 69 | 8 | MORF_ARL3 | |
| Computational | RNA splicing. | 7.84e-04 | 65 | 69 | 4 | MODULE_183 | |
| Computational | Neighborhood of FOSL1 | 1.09e-03 | 406 | 69 | 9 | MORF_FOSL1 | |
| Disease | cD177 antigen measurement | 3.97e-07 | 18 | 102 | 4 | EFO_0021866 | |
| Disease | melanoma | 2.55e-05 | 248 | 102 | 7 | C0025202 | |
| Disease | Joint Instability | 3.54e-05 | 3 | 102 | 2 | C0022410 | |
| Disease | Joint laxity | 3.54e-05 | 3 | 102 | 2 | C0086437 | |
| Disease | congenital nystagmus (is_implicated_in) | 3.54e-05 | 3 | 102 | 2 | DOID:9649 (is_implicated_in) | |
| Disease | Osteoarthritis of hip | 4.38e-05 | 20 | 102 | 3 | C0029410 | |
| Disease | pregnancy-specific beta-1-glycoprotein 9 measurement | 7.07e-05 | 4 | 102 | 2 | EFO_0801909 | |
| Disease | Usher Syndrome | 7.07e-05 | 4 | 102 | 2 | C0271097 | |
| Disease | Usher syndrome, type 1A | 1.18e-04 | 5 | 102 | 2 | C2931205 | |
| Disease | Usher Syndrome, Type II | 1.18e-04 | 5 | 102 | 2 | C1568249 | |
| Disease | USHER SYNDROME, TYPE IB (disorder) | 1.18e-04 | 5 | 102 | 2 | C1848638 | |
| Disease | USHER SYNDROME, TYPE IA, FORMERLY | 1.18e-04 | 5 | 102 | 2 | C1848639 | |
| Disease | USHER SYNDROME, TYPE I, FRENCH VARIETY, FORMERLY | 1.18e-04 | 5 | 102 | 2 | C1848640 | |
| Disease | syntactic complexity measurement, specific language impairment | 1.18e-04 | 5 | 102 | 2 | EFO_0007799, EFO_1001510 | |
| Disease | Usher syndrome type 1 | 1.18e-04 | 5 | 102 | 2 | cv:C1568247 | |
| Disease | cervical cancer (is_implicated_in) | 1.52e-04 | 30 | 102 | 3 | DOID:4362 (is_implicated_in) | |
| Disease | pregnancy-specific beta-1-glycoprotein 4 measurement | 1.76e-04 | 6 | 102 | 2 | EFO_0801907 | |
| Disease | N1-methyladenosine measurement | 1.76e-04 | 6 | 102 | 2 | EFO_0021122 | |
| Disease | Usher Syndrome, Type I | 1.76e-04 | 6 | 102 | 2 | C1568247 | |
| Disease | Nonsyndromic Deafness | 1.83e-04 | 81 | 102 | 4 | C3711374 | |
| Disease | Hereditary retinal dystrophy | 2.46e-04 | 7 | 102 | 2 | C0154860 | |
| Disease | Usher syndrome | 2.46e-04 | 7 | 102 | 2 | cv:C0271097 | |
| Disease | Usher Syndrome, Type III | 2.46e-04 | 7 | 102 | 2 | C1568248 | |
| Disease | visual epilepsy (biomarker_via_orthology) | 2.74e-04 | 90 | 102 | 4 | DOID:11832 (biomarker_via_orthology) | |
| Disease | pleural tuberculosis (is_marker_for) | 5.23e-04 | 10 | 102 | 2 | DOID:106 (is_marker_for) | |
| Disease | Immature Reticulocyte Fraction Measurement | 5.23e-04 | 10 | 102 | 2 | EFO_0009253 | |
| Disease | Gastrointestinal Stromal Sarcoma | 5.82e-04 | 47 | 102 | 3 | C3179349 | |
| Disease | end stage renal disease (biomarker_via_orthology) | 5.82e-04 | 47 | 102 | 3 | DOID:783 (biomarker_via_orthology) | |
| Disease | Gastrointestinal Stromal Tumors | 6.99e-04 | 50 | 102 | 3 | C0238198 | |
| Disease | Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive | 7.40e-04 | 51 | 102 | 3 | cv:CN043650 | |
| Disease | hypertension (implicated_via_orthology) | 1.03e-03 | 128 | 102 | 4 | DOID:10763 (implicated_via_orthology) | |
| Disease | colon cancer (is_marker_for) | 1.13e-03 | 59 | 102 | 3 | DOID:219 (is_marker_for) | |
| Disease | high grade glioma (biomarker_via_orthology) | 1.21e-03 | 15 | 102 | 2 | DOID:3070 (biomarker_via_orthology) | |
| Disease | Hereditary hearing loss and deafness | 1.68e-03 | 146 | 102 | 4 | cv:C0236038 | |
| Disease | colorectal cancer (is_marker_for) | 2.19e-03 | 157 | 102 | 4 | DOID:9256 (is_marker_for) | |
| Disease | Nonsyndromic genetic hearing loss | 2.35e-03 | 76 | 102 | 3 | cv:C5680182 | |
| Disease | urinary bladder cancer (is_implicated_in) | 2.35e-03 | 76 | 102 | 3 | DOID:11054 (is_implicated_in) | |
| Disease | left atrial function | 2.38e-03 | 21 | 102 | 2 | EFO_0004294 | |
| Disease | colorectal carcinoma (is_implicated_in) | 2.61e-03 | 22 | 102 | 2 | DOID:0080199 (is_implicated_in) | |
| Disease | phosphatidylcholine 34:3 measurement | 2.61e-03 | 22 | 102 | 2 | EFO_0010377 | |
| Disease | proprotein convertase subtilisin/kexin type 9 measurement | 2.61e-03 | 22 | 102 | 2 | EFO_0009312 | |
| Disease | Deafness | 3.37e-03 | 25 | 102 | 2 | C0011053 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RSPIAYERGRIYFDN | 56 | Q5H9S7 | |
| TILYYGRRRGIALPA | 26 | P00813 | |
| YFRRGQTCYRPLRGD | 26 | Q9UBR2 | |
| LGYRTGYAYRHPLIR | 381 | Q9UEY8 | |
| IRGGVFYIPEYLNRS | 226 | P54646 | |
| TDRGIPYRRGYLLYG | 216 | Q9Y276 | |
| QVGYIRVRFYEGPEL | 691 | P49747 | |
| GTYVQLRRHPGRRYE | 196 | Q86SQ6 | |
| VRDRGLFYYRLLLVG | 511 | Q9Y6B7 | |
| APGRRLEEYGAFYVG | 206 | Q9BQC3 | |
| GRQYLLRPGDYRRYH | 141 | P11844 | |
| YVPNAGRGLVRLEYR | 171 | P27695 | |
| RDVGPYGIRSEYCIR | 1951 | Q12830 | |
| ALERGYYPVIFHRRG | 181 | Q6UXT9 | |
| RDLGYYLARRPVDGF | 636 | Q149M9 | |
| PLRFREVPYAYIREG | 156 | P50281 | |
| SLVGPQIYLCYRRGR | 81 | Q7Z401 | |
| FRPGVRYDFRIYGLS | 591 | Q99650 | |
| RGEVEFRNYSVRYRP | 1286 | O15438 | |
| FRNYSVRYRPGLDLV | 1291 | O15438 | |
| ILGRYYETGSIRPRA | 56 | P26367 | |
| YRSRVRPCVVYGGAD | 291 | O00571 | |
| GRIVYGLRPGRSYQF | 1316 | P23467 | |
| TIFYRDRLGLYPRFD | 76 | Q12891 | |
| AILYYYQSGGRLRRP | 91 | Q09470 | |
| VPRAGYRGIVTFQFR | 411 | P26572 | |
| AHRQGYGPFLERYRL | 626 | Q9UBC5 | |
| RPGFAAVELRLRNYY | 616 | P43405 | |
| GTLQYREDPRFTGYR | 836 | O60486 | |
| RVARLLLYGYREGFD | 266 | P53370 | |
| LRLYPEYGAAFRAGL | 666 | Q9UQ05 | |
| GRRGRVVNDLYRYKP | 161 | Q96KN1 | |
| RFVGRPGDYVYIFRS | 631 | Q5XXA6 | |
| QRYGRRPYGVGLLIA | 121 | P25786 | |
| YYRRALEIYATRLGP | 346 | Q9H0B6 | |
| YRRFLELFLGEFRGP | 11 | Q8WY54 | |
| RGRKVYLEDGFAYVP | 196 | P49643 | |
| GFQYRALYPFRRERP | 6 | O00459 | |
| FQPYYGEGGRILEIR | 1341 | Q96QU1 | |
| PYQAERFRRLGYVSL | 86 | O60308 | |
| ILYYYQSGGRLRRPV | 96 | P17658 | |
| LRYRIIYRPVAGGES | 751 | Q99715 | |
| VYFAQYGEPREGGRR | 91 | Q8NDZ4 | |
| YLARELAAGYRRGDP | 151 | O75976 | |
| VILREYGFRFVRRGP | 1091 | O60266 | |
| ARGVYAPEDVYRFRP | 2436 | Q8TEP8 | |
| SAGVPNREGLRYYRR | 161 | Q9UEF7 | |
| RRLFGVYCYRAPGAP | 356 | Q86UW8 | |
| VQYLYRVFCRLRPGV | 326 | Q13206 | |
| RYRLRLVEDGLYGAP | 461 | Q16478 | |
| YYALVVRGRVRPGET | 1656 | P49327 | |
| GQRIIYGPAYSGRER | 86 | Q00888 | |
| GPYQCEIRDRYGGIR | 306 | Q00888 | |
| RPIFSNRGDFRGYCY | 736 | Q15020 | |
| GRRRRGELPCDDYGY | 746 | Q12770 | |
| GYILITEFVGRRYRR | 221 | O15244 | |
| RFYRAPEVILGARYG | 386 | Q92630 | |
| VYRNGDPFYAGRRVV | 21 | Q9UHG0 | |
| YIRLTQYIDGQGRPR | 511 | Q13555 | |
| LRRYELLFYPGDGSV | 21 | Q9Y5B8 | |
| GPYQCEIRDRYGGIR | 306 | P11464 | |
| RKRPYEENRGRGYFE | 171 | Q9BUJ2 | |
| ARYYVLARGGLQVEP | 436 | Q9H239 | |
| EGGLRKVRPYYFDFR | 136 | Q8IZ73 | |
| RFGEVRPYFYLGGAR | 456 | Q9UPQ4 | |
| PRRFGVYLDYEAGRL | 576 | Q8WV44 | |
| ERKIGRAGYRLPLAY | 216 | Q7Z5M5 | |
| IRAYEQLGYRAFGTP | 126 | Q99624 | |
| DYGQCRLRVEFPRTY | 76 | Q13242 | |
| RARYEEVQRYSRGGP | 61 | Q504Y2 | |
| EYYRGLVPILFRNGL | 171 | Q9H1U9 | |
| GFFPTPRYLLDYRGR | 856 | Q7RTY7 | |
| GPYQCEIRDRYGGLR | 306 | Q00887 | |
| VVVFVSYFGGRGRRP | 181 | Q9H2Y9 | |
| RILGSYYGFRGEALP | 116 | Q86VD7 | |
| EYYRGLVPILFRNGL | 171 | Q3SY17 | |
| GPYQCEIRDRYGGIR | 306 | Q13046 | |
| RILAYVFPGVTRLYG | 206 | Q9H0A9 | |
| RSGETGYVPPAYLRR | 41 | Q9NZQ3 | |
| LRREFGRYGPIVDVY | 26 | Q8WXF0 | |
| IPLDFYTRRPRGFAY | 41 | Q8WXF0 | |
| RLVFREEGYLAFYRG | 276 | Q9BSK2 | |
| DFGLARAFGIPIRVY | 146 | P06493 | |
| AIRFYYGDRVCARPL | 76 | O75339 | |
| GYRRFDPARGMEYTL | 451 | Q8IZ52 | |
| RYGAEIVRRYRAGAG | 236 | Q8NCH0 | |
| EEYPGRRNIYRISIG | 416 | Q12884 | |
| RKLYGPLCGYYLGRR | 71 | P24557 | |
| LRREFGRYGPIVDVY | 26 | O75494 | |
| VPLDFYTRRPRGFAY | 41 | O75494 | |
| DTAYVLFYRQRPREG | 916 | Q9P2H5 | |
| TPYRVSIYGVIRGYR | 1411 | P24821 | |
| KHLLYLGRPEGYRGR | 881 | Q9H3T2 | |
| EFYARRKRLGGQTPY | 6 | Q96LQ0 | |
| NYRYRAGFVLAPIGL | 396 | Q99835 | |
| YGEFPGDERRKLIRY | 551 | P18887 | |
| LEREGPRAFYRGYLP | 326 | Q9BV35 | |
| CLNPRYRGRVYVGFT | 21 | Q9BQ83 | |
| YRGRLAYLPVGRVGS | 206 | Q9NYA1 | |
| GTYPRLEEYRRGILG | 106 | Q0VAF6 | |
| NGGYYRPEGTLERRR | 606 | Q63HR2 | |
| LERRRLAYGGYEGSP | 616 | Q63HR2 | |
| FGYRAPGYREVVILE | 666 | Q63HR2 | |
| FVTGRSRLPARIYIY | 791 | Q5T447 | |
| RVRRAGYAFRQAYEP | 626 | O43795 | |
| GIIRGAVEPDRYVLY | 351 | Q9UQQ1 | |
| YASGERRAYGPLFLR | 226 | Q9BRK3 | |
| RIRRAGYPIRYSFVE | 666 | Q13402 |